Lv7
5000 积分 2022-02-05 加入
Comparative efficacy of glucose‐lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta‐analysis
25天前
已完结
Sodium-Glucose Cotransporter 2 Inhibitors and Stroke Risk in Patients with Diabetes and Stroke Risk Factors: A Real-World Cohort Study
29天前
已完结
Heterogeneous cardiovascular effects of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a causal forest and target trial emulation study
29天前
已完结
Comparison of GLP-1 receptor agonists and other Glucose-Lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and Obesity: A Spanish Real-World Population-Based study
29天前
已完结
Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon‐like peptide‐1 receptor agonists or sodium‐glucose cotransporter‐2 inhibitors: A real‐world study in two Italian cohorts
29天前
已完结
Comparative cardiovascular effectiveness of glucagon‐like peptide‐1 receptor agonists versus sodium‐glucose cotransporter‐2 inhibitors in patients with type 2 diabetes: A population‐based cohort study
29天前
已完结
The Role of Diabetes and SGLT2 Inhibitors in Cerebrovascular Diseases
29天前
已完结
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
29天前
已完结
Cardiometabolic and renal benefits of sodium–glucose cotransporter 2 inhibitors
29天前
已完结
Cardiovascular and renal effects of the combination therapy of a GLP-1 receptor agonist and an SGLT2 inhibitor in observational real-life studies
29天前
已完结
皖公网安备34019202002308
